BackCitius Pharmaceuticals- Warrants(02/08/2022) Overview

Citius Pharmaceuticals- Warrants(02/08/2022) Current Assets

Citius Pharmaceuticals- Warrants(02/08/2022)'s current assets is $43M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$43.33M
↑ 76.06% YoYΔ $18.72M vs prior year quarter

Peer trimmed avg / median

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) Current Assets History

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) vs. peers: Current Assets Comparison

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Citius Pharmaceuticals- Warrants(02/08/2022) (CTXRW) FAQ

As of the most recent data (June 2026), CTXRW shows a current assets of $43M. That compares with $25M in the prior-year period — up 76.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTXRW's current assets is now $43M (was $25M) — a 76.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Citius Pharmaceuticals- Warrants(02/08/2022) is outperforming or lagging.

Tracking CTXRW's current assets over time shows whether Citius Pharmaceuticals- Warrants(02/08/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $43M That compares with $25M in the prior-year period — up 76.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Citius Pharmaceuticals- Warrants(02/08/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $43M) with ownership activity and broader fundamentals.

Citius Pharmaceuticals- Warrants(02/08/2022)'s current assets is $43M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.